9 Results for "

heteroaryl compound

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "heteroaryl compound" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-148673
CAS No.: 2455427-91-3
Purity:  99.97%
Synonyms: AZD0780; PCSK9-IN-12
Target:  

PCSK9

Laroprovstat (AZD0780) is an orall active PCSK9 inhibitor. PCSK9-IN-12 has bind affinity for PCSK9 with a Kd value of <200 nM. Laroprovstat binds to a pocket in the PCSK9 C-terminal domain and does not affect the PCSK9-LDL receptor (LDLR) interaction. Laroprovstat inhibits lysosomal trafficking of PSCK9-LDLR complexes and prevents PCSK9-induced LDLR degradation. Laroprovstat can be used for the research of hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-W002251
CAS No.: 5381-20-4
Benzo[b]thiophene-3-carbaldehyde is a 3-formyl-substituted benzo[b]thiophene derivative that acts as an oxidizable substrate to convert to benzo[b]thiophene-3-carboxylic acid under liquid-phase conditions. Compared with analogs such as benzaldehyde and thiophene-2-carbaldehyde, Benzo[b]thiophene-3-carbaldehyde has lower oxidation difficulty, and can significantly increase the reaction rate in the presence of initiators (such as Na +Br - or DBA). Benzo[b]thiophene-3-carbaldehyde also serves as a key starting material for the synthesis of compounds including heteroaryl chalcones .
loading...
    loading...
Cat. No.: HY-178769
CAS No.: 3084713-99-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

GLP-1R agonist 36 (Compound 53) is a GLP-1R agonist with a total of four isomers. GLP-1R agonist 36 can be used for the studies of diabetes and obesity.
loading...
    loading...
Cat. No.: HY-178768
CAS No.: 3092875-81-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

GLP-1R agonist 35 (Compound 111-2) is a GLP-1R agonist with an EC50 of 0-10 nM. GLP-1R agonist 36 can be used for the studies of diabetes and obesity .
loading...
    loading...
Cat. No.: HY-135830
CAS No.: 2242465-58-1
Research Areas:  

Cancer

AHR antagonist 4 is a 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compound and a potent aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 293, has an IC50 of 82.2 nM. AHR antagonist 4 has anti-cancer effects .
loading...
    loading...
Cat. No.: HY-153592
CAS No.: 850020-01-8
Purity:  ≥97.0%
Target:  

Glycosidase

Research Areas:  

Others

Therapeutic agent-1 is a heteroaryl compound that can be used in Gaucher disease glucocerebrosidase activity enzyme replacement therapy .
loading...
    loading...
Cat. No.: HY-143582
CAS No.: 2640300-87-2
Research Areas:  

Cancer

ATX inhibitor 9 is a potent inhibitor of ATX. ATX inhibitor 9 is a thickened heteroaryl derivatives compound. Autotaxin (ATX), also known as ENPP2, is a secreted enzyme that is highly expressed mainly in cancer cells, bronchial epithelial cells and alveolar macrophages in the lung. ATX inhibitor 9 has the potential for the research of cancer or fibrous degenerative disease (extracted from patent WO2021078227A1, compound 3) .
loading...
    loading...
Cat. No.: HY-W1059094
CAS No.: 5998-89-0
Target:  

Drug Intermediate

Research Areas:  

Others

2-(Pyridin-2-yl) oxazole is a bis-heteroaryl compound that serves as a pharmaceutical intermediate for synthesizing active compounds, such as CP4H1 inhibitors .
loading...
    loading...
Cat. No.: HY-184093
CAS No.: 2648407-86-5
Synonyms: Rexaceractum
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Rexaceract (Rexaceractum) is a heteroaryl compound that binds to β-glucocerebrosidase. Rexaceract maintains the conformational stability of β-glucocerebrosidase and exhibits activating activity. Rexaceract can be used in the research of nervous system-related diseases such as neurodegenerative diseases with Parkinsonism, epilepsy, and schizophrenia .
loading...
    loading...